Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2021-05-21 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2021-05-21 English
6-K
Foreign Filer Report
2021-05-21 English
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
Regulatory Filings Classification · 95% confidence The document is a corporate announcement from Genmab regarding a positive CHMP opinion for a drug formulation. It is under 15,000 characters, explicitly titled 'Company Announcement', and includes a link to an attachment at the end. According to the 'Menu vs Meal' rule, announcements of this nature that provide links to external reports or simply announce regulatory news are classified as Regulatory Filings (RNS).
2021-05-21 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is titled "Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation...". It is explicitly labeled as a "Company Announcement" and details a regulatory milestone (positive opinion from the CHMP of the EMA) regarding a drug formulation. This type of announcement, which communicates a specific, non-financial regulatory or operational event, fits best under the general category of regulatory announcements or news releases that are not standard financial reports (like 10-K, IR, or ER). Since it is a specific announcement about a regulatory step (CHMP opinion) and not a full financial report, it is classified as a Regulatory Filing (RNS) as the most appropriate general category for significant, non-standard corporate news that doesn't fit the other specific codes (like M&A, Dividend, or Management Change). It is not a proxy statement (DEF 14A/PSI), an earnings release (ER), or a full interim/annual report (IR/10-K).
2021-05-21 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is a company announcement regarding transactions in shares by managerial employees and their closely associated persons, explicitly citing Article 19 of Regulation No. 596/2014 on Market Abuse. This falls under the category of Director's Dealing (DIRS). Although there is an attachment, the text itself serves as the official disclosure of these transactions.
2021-05-21 English
Director's Dealing 2021
Director's Dealing Classification · 99% confidence The document is titled "Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons" and explicitly references compliance with Article 19 of Regulation No. 596/2014 on Market Abuse. It details a specific sale of shares by an Executive Vice President (Judith Klimovsky). This content directly corresponds to the reporting requirements for insider trading or director's dealings. Among the provided codes, 'Director's Dealing (Code: DIRS)' is the most appropriate classification for reports detailing personal share transactions by company directors and executives.
2021-05-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.